Jean-Luc Butel

Board positions
In his capacity as global healthcare advisor, Jean-Luc has served on numerous boards and committees, including the Singapore Economic Development Board (EDB), the National Medical Research Council (NMRC) and Singapore’s Accelerate (ASTAR).
He currently serves on the boards of several prominent organisations, such as Rani Therapeutics, ICON Group, Takeda Pharmaceutical, Jana Care and Singapore Agency for Science Technology and Research (A*STAR), where he is on the board of the DxD Hub and Chair of the Investment Committee.
Between 2017-2024, Jean-Luc was a Board member at Novo Holdings, and since then he has served on the Novo Advisory Group.

Career
2015 – 2015     President – International, Baxter International, Singapore
2012 – 2014     Corporate Officer; Operating Committee Member; Corporate Vice President; President – International, Baxter International, US
2011 – 2012      Corporate Officer; Executive Committee Member; Executive Vice President; Group President – International, Medtronic, Singapore
2008 – 2010    Group President – International, Medtronic, Japan
2003 – 2008   Corporate Officer; Executive Committee Member; Senior Vice President, Medtronic; President, Medtronic Asia Pacific, Japan
1991 – 1999      Various positions (General Manager, Microbiology, Nippon; President, Nippon; Vice President, Consumer Healthcare, North America; Corporate Officer, President, Worldwide Consumer Healthcare), Becton Dickinson, Japan & US
1990 – 1991      Marketing Director, Johnson & Johnson Medical - Singapore, Indonesia, Malaysia, Singapore
1988 – 1990     China Project Manager, Johnson & Johnson International, Hong Kong
1985 – 1988     General Manager, Johnson & Johnson, Fiji

Education

Jean-Luc holds a BA in International Affairs from The George Washington University, and an MBA in International Management from the American Graduate School of International Management.